These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1154343)

  • 1. Fibrinolysis in relation to circulation through the legs in diabetics.
    Almér LO; Lilja B
    Thromb Res; 1975 Jul; 7(1):67-74. PubMed ID: 1154343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coppolino E; Squadrito G
    Minerva Med; 1979 May; 70(22):1597-9. PubMed ID: 450299
    [No Abstract]   [Full Text] [Related]  

  • 3. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
    Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms responsible for hyperfibrinogenaemia in the diabetics ].
    Amado JA; Sedano MC; Mazo E; Vadillo V; Vidal JI
    Sangre (Barc); 1982; 27(2):145-9. PubMed ID: 7123434
    [No Abstract]   [Full Text] [Related]  

  • 6. On fibrinolysis in diabetes mellitus.
    Almér LO; Nilsson IM
    Acta Med Scand; 1975; 198(1-2):101-6. PubMed ID: 52286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy and the fibrinolytic system.
    Almér LO; Pandolfi M; Nilsson IM
    Diabetes; 1975 Jun; 24(6):529-34. PubMed ID: 49282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on endogenous fibrinolytic activity in diabetes mellitus.
    Almér LO
    J Med; 1975; 6(5-6):351-67. PubMed ID: 56414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between retinopathy and impaired peripheral arterial circulation in insulin-dependent diabetic patients.
    Riccardi G; Vaccaro O; Rivellese A; Romano G; Cambri V; Rubba P; Pauciullo P; Greco G; Iovine C; Mancini M
    Arteriosclerosis; 1988; 8(5):509-14. PubMed ID: 3190557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum glycoproteins in diabetes mellitus; quantitative immunological determination of acid alpha 1-glycoprotein, Gc, alpha 2-macroglobulin and hemopexin in diabetics with and without angiopathy].
    Cleve H; Alexander K; Mitzkat HJ; Nissen P; Salzmann I
    Diabetologia; 1968 Jan; 4(1):48-55. PubMed ID: 4984806
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic activity in hemiplegic patients.
    Karaca M; Nilsson IM
    Acta Med Scand; 1971 Apr; 189(4):325-9. PubMed ID: 5115509
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired hemorheological properties in diabetic patients with lower limb arterial ischaemia.
    Le Devehat C; Khodabandehlou T; Vimeux M
    Clin Hemorheol Microcirc; 2001; 25(2):43-8. PubMed ID: 11790869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of leg arterial compliance of normal subjects and diabetics using impedance plethysmography.
    Kim DW; Kim SC
    Ann N Y Acad Sci; 1999 Apr; 873():112-20. PubMed ID: 10372158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some parameters of hemostasis and fibrinolysis in diabetic patients].
    Telejko B; Zonenberg A; Borejszo I; Kinalska I
    Pol Arch Med Wewn; 1998 Aug; 100(2):133-8. PubMed ID: 10101928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
    Janody D; Droulle C; Adjizian JC; Ostermann G; Poynard JP; Jeunehomme G; Leutenegger M; Potron G
    J Mal Vasc; 1982; 7(3):221-4. PubMed ID: 6815291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.
    Morale M; De Negri F; Carmassi F
    Diabetologia; 1997 Jun; 40(6):735-7. PubMed ID: 9222656
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinogen-fibrin degradation products in diabetes mellitus].
    Alakhverdian R; Koev D
    Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatotropic hormone, diabetes and diabetic angiopathy].
    Dobrev DG
    Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of the integrated capillary pressure in reactive hyperemic phase in diabetics and normal subjects.
    Alexander K; Teusen R; Mitzkat HJ
    Bibl Anat; 1967; 9():516-9. PubMed ID: 6029901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.